Efficacy of lenvatinib in patients with advanced pancreatic (panNETs) and gastrointestinal (giNETs) grade 1/2 (G1/G2) neuroendocrine tumors: Results of the international phase II TALENT trial (GETNE 1509).
暂无分享，去创建一个
L. Antonuzzo | N. Fazio | J. Valle | R. García-Carbonero | M. Raderer | J. Capdevila | E. Grande | N. Reed | A. Spallanzani | S. Tafuto | T. Ibrahim | A. Berruti | V. Alonso | A. Custodio | C. Lopez | A. La Casta | J. Hernando | I. Sevilla García | P. Jiménez Fonseca | A. Teule